Biological evaluation of combinations of tyrosine kinase inhibitors with Inecalcitol as novel treatments for human chronic myeloid leukemia

• Главные авторы: Luma Al-Ali (Автор), Raad J. Al-Ani (Автор), Maysaa M. Saleh (Автор), Alaa M. Hammad (Автор), Duaa A. Abuarqoub (Автор), Bashaer Abu-Irmaileh (Автор), Abdallah Y. Naser (Автор), Manal M. Najdawi (Автор), Manal M. Abbas (Автор), Jamal Alyoussef Alkrad (Автор)
• Формат: ‌
• Опубликовано: Elsevier, 2024-02-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: The use of tyrosine kinase inhibitors (TKIs) as a treatment for chronic myeloid leukemia (CML) has improved the natural history of the disease and increased the duration of survival. Tyrosine kinase inhibitors represent the success of target therapies that work on molecular targets, alth...